BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28853185)

  • 1. A camelid nanobody against EGFR was easily obtained through refolding of inclusion body expressed in Escherichia coli.
    Xu L; Song X; Jia L
    Biotechnol Appl Biochem; 2017 Nov; 64(6):895-901. PubMed ID: 28853185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prokaryotic expression and refolding of EGFR extracellular domain and generation of phage display human scFv against EGFR.
    Zhou Y; Zhang J; Jin H; Chen Z; Wu Q; Li W; Yue M; Luo C; Wang M
    Biomed Pharmacother; 2013 Oct; 67(8):737-43. PubMed ID: 23639232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of dilution refolding conditions for a camelid single domain antibody against human beta-2-microglobulin.
    Bao X; Xu L; Lu X; Jia L
    Protein Expr Purif; 2016 Jan; 117():59-66. PubMed ID: 26386406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of humanized nanobodies targeting the dimer interface of epidermal growth factor receptor (EGFR).
    Zhu H; Zhao L; Li Z; Wen B; Qiu C; Liu M; Xu Z; Hu S; Li H
    Protein Expr Purif; 2019 May; 157():57-62. PubMed ID: 30735705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [On-column refolding and purification of human EGF receptor L2 domain inclusion body overexpressed in Escherichia coli].
    Xu LH; Hong A; He XH
    Sheng Wu Gong Cheng Xue Bao; 2005 Jul; 21(4):597-603. PubMed ID: 16176099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of a mono-biotinylated EGFR nanobody in the E. coli periplasm using the pET22b vector.
    Noor A; Walser G; Wesseling M; Giron P; Laffra AM; Haddouchi F; De Grève J; Kronenberger P
    BMC Res Notes; 2018 Oct; 11(1):751. PubMed ID: 30348204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study and evaluation of anti-EGFR nanobodies expressed in Pichia pastoris and Escherichia coli as antitumor moieties.
    Xi X; Sun W; Li H; Fan Q; Zhang X; Sun F
    Protein Expr Purif; 2021 Aug; 184():105888. PubMed ID: 33857600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and evaluation of a single domain antibody against human epidermal growth factor receptor (EGFR).
    Ahdi Khosroshahi S; Farajnia S; Ghiamirad M; Tanomand A; Veisi K; Rahbarnia L; Akbari B
    Protein Expr Purif; 2016 Apr; 120():59-64. PubMed ID: 26690373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo detection of small tumour lesions by multi-pinhole SPECT applying a (99m)Tc-labelled nanobody targeting the Epidermal Growth Factor Receptor.
    Krüwel T; Nevoltris D; Bode J; Dullin C; Baty D; Chames P; Alves F
    Sci Rep; 2016 Feb; 6():21834. PubMed ID: 26912069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational nanobodies reveal tethered epidermal growth factor receptor involved in EGFR/ErbB2 predimers.
    Nevoltris D; Lombard B; Dupuis E; Mathis G; Chames P; Baty D
    ACS Nano; 2015 Feb; 9(2):1388-99. PubMed ID: 25603171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel recombinant immunotoxin of EGFR specific nanobody fused with cucurmosin, construction and antitumor efficiency in vitro.
    Deng C; Xiong J; Gu X; Chen X; Wu S; Wang Z; Wang D; Tu J; Xie J
    Oncotarget; 2017 Jun; 8(24):38568-38580. PubMed ID: 28445134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High affinity nanobodies against human epidermal growth factor receptor selected on cells by E. coli display.
    Salema V; Mañas C; Cerdán L; Piñero-Lambea C; Marín E; Roovers RC; Van Bergen En Henegouwen PM; Fernández LÁ
    MAbs; 2016 Oct; 8(7):1286-1301. PubMed ID: 27472381
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Piramoon M; Hosseinimehr SJ; Omidfar K; Noaparast Z; Abedi SM
    Chem Biol Drug Des; 2017 Apr; 89(4):498-504. PubMed ID: 27650045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a Recombinant Monospecific Anti-PLGF Bivalent Nanobody and Evaluation of it in Angiogenesis Modulation.
    Nikooharf A; Arezumand R; Mansouri K; Khoshi AH; Namdar Ahmadabad H
    Mol Biotechnol; 2020 Dec; 62(11-12):580-588. PubMed ID: 32975735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and purification of a toxin-linked conjugate targeting epidermal growth factor receptor in Escherichia coli.
    Ma C; Li Y; Li Z; Huang H; Xu K; Xu H; Bai J; Li X; Zhao G
    Protein Expr Purif; 2012 May; 83(1):1-7. PubMed ID: 22381467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production and Characterization of Novel Camel Single Domain Antibody Targeting Mouse Vascular Endothelial Growth Factor.
    Kazemi-Lomedasht F; Behdani M; Habibi-Anbouhi M; Shahbazzadeh D
    Monoclon Antib Immunodiagn Immunother; 2016 Jun; 35(3):167-71. PubMed ID: 27167350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant λ bacteriophage displaying nanobody towards third domain of HER-2 epitope inhibits proliferation of breast carcinoma SKBR-3 cell line.
    Shoae-Hassani A; Mortazavi-Tabatabaei SA; Sharif S; Madadi S; Rezaei-Khaligh H; Verdi J
    Arch Immunol Ther Exp (Warsz); 2013 Feb; 61(1):75-83. PubMed ID: 23224340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering an anti-granulocyte colony stimulating factor receptor nanobody for improved affinity.
    Bakherad H; Farahmand M; Setayesh N; Ebrahim-Habibi A
    Life Sci; 2020 Sep; 257():118052. PubMed ID: 32634431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of three in-vitro refolding methods for human-derived anti-CTLA4 scFv expressed in E. coli].
    Huang Q; Chen L; Zeng L; Wan L; Li S; Lu X; Cheng J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Apr; 23(2):388-91. PubMed ID: 16706373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.
    Gainkam LO; Huang L; Caveliers V; Keyaerts M; Hernot S; Vaneycken I; Vanhove C; Revets H; De Baetselier P; Lahoutte T
    J Nucl Med; 2008 May; 49(5):788-95. PubMed ID: 18413403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.